1 out of 4 CBD Products is NOT Tested

for Microbial Content, Pesticides, or Heavy Metals 

The CBD industry’s peer-reviewed watchdog Leafreport.com recently undertook an comprehensive review of 2946 products from 136 brands to verify how many were being tested by third-party facilities for purity or potency. The report also released a list of the top ten most transparent brands.

“The CBD industry is still very unregulated,” said Shafir, the head of product at Leafreport. “There have been many cases of companies selling products that contain little to no CBD–that’s why third-party testing is so critical for brands in this industry.”

Pure, Clean CBD? It’s Unlikely: Only 13% of Brands Tested Almost All of Their Products for Purity

‘Clean’, ‘safe’, ‘natural’, or ‘pure’ CBD are pivotal selling points for many CBD brands. However, these buzz words are meaningless without the evidence to support such claims.

One of the key findings of the report was that only 13% of CBD companies tested almost all of their products for detectable levels of contaminants such as heavy metals, pesticides, or microbial content. But 25% didn’t test any of their products for purity at all.

“We were stunned to find that of the big-name brands we reviewed, one in four didn’t test any of their products for the presence of contaminants,” said Shafir. “It’s particularly concerning given that hemp, from which CBD is extracted, is a phyto-remedial plant that absorbs toxins and heavy metals from the soil”.

Do Most CBD Products Deliver the Promised Potency? Don’t Bet on It–84% Don’t Measure within the Acceptable Variance

Among other key findings exposed by the report were significant discrepancies between the product’s labelled potency compared with the contents of the bottle.

The concentration of CBD stated on a product label must match the concentration measured by the testing laboratory within a 10% variance, which means that a high-quality CBD product is expected to have CBD levels that are within 90–110% of what is advertised.

84% of the 2946 products tested were found to be outside the limits of acceptable variance. Leafreport also uncovered that only 42% of brands tested all their products for potency.

“The number of brands sidestepping third-party potency testing, or testing outside the allowable variance, is a genuine source of concern,” commented Shafir.

“Testing to ensure the potency of your product is accurate is a fundamental aspect of brand integrity–especially in the case of CBD products that are frequently used as medicine. Children diagnosed with rare forms of pediatric epilepsy use CBD to help control seizures, so it’s absolutely essential that their caregivers know what’s in the bottle to get dosage right.”

Less is More: Brands with Fewer than 8 Products are More Likely to Test for Both Purity and Potency

Another telling finding revealed by the report was that brands offering 7 products or less were more likely to test most of their products for both potency and purity, as opposed to brands with over 40 products. These results suggest that third-party testing may be more manageable, and financially practicable, for brands with fewer products.

It’s Time for CBD Brands to Level Up and Become More Accountable

Overall, the findings of the report indicate that vast discrepancies and unknowns characterize what consumers believe they are purchasing–and the actual contents of the CBD product.

“The excitement generated by CBD has led to the explosion of largely unregulated industry that must become more accountable to consumers,” reflected Shafir.

Transparency report summary

 

http://d1h.7b5.myftpupload.com/industry-insights/1-out-of-4-cbd-products-is-not-tested/?fbclid=IwAR0ih9_—UVMaK3xssQ6gXX17GwuP4fDbbXSRKDVZMz0krJ7UKUkkIpUf4

 

 

  • CannaAid and Peak: Something new for everyone.

Recent Articles

How Marcos Hurtado continues a legacy of service with Lambo Industries
ATEC’s Unusual Approach to Trade Shows
Retailers may feel like they are working overtime in December. You have to deal with inventory taxes, holiday shoppers, and cleaning out shelves for the new year. However, the right strategies can help you turn dead stock into cash flow, protect your profits, and prepare for 2026. This guide offers tested tactics to help you do that.
The single largest government investment in psychedelics is happening down the road from rodeos, ranches, and rabid football fans. Welcome to Texas, where ibogaine research is a public good.
For Sammie Pyle, cannabis has been a life-changing medicine, and she wants everyone to know about it. A registered nurse with a background in critical care and travel nursing, Sammie became a frontline healthcare worker in 2020, working in COVID ICUs across the country. As a result of that work, she was diagnosed with PTSD, survivor’s guilt, and insomnia. “The doctor wanted to give me a lot of prescriptions, but I already felt numb,” she says. “I needed something to bring me back to myself. So I chose a different path: the cannabis route.”
Before you pop the champagne (or, in my case, spark the bowl) on New Year’s Eve, don’t forget to tie up any remaining loose ends with your business. Unfinished tasks could cost you thousands if left dangling for too long, so start the New Year off right by taking care of any unresolved issues before January 1st.
There’s no holiday more prone to mythmaking than Christmas. Across our TVs, stories enshrine ridiculous origins to modern traditions, cartoon characters regularly save the holiday from the forces of grinchdom, and modern love flourishes for career women stuck in small towns. But these yuletide concoctions aren’t merely dessert; they’re flavoring added to medicine. Our stories cover up an uncomfortable truth: many of our holiday traditions stem from pagan revelry that included everything from psychedelics to orgies.
Boost profits with these holiday cannabis sales strategies to build Q1 momentum through promotions, gift cards, bundling, and future-focused planning.